Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1897 to 1898 of 1898 entries
Sorted by: Best Match Show Resources per page
Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers.

EBioMedicine

Moncunill G, Aguilar R, Ribes M, Ortega N, Rubio R, Salmerón G, Molina MJ, Vidal M, Barrios D, Mitchell RA, Jiménez A, Castellana C, Hernández-Luis P, Rodó P, Méndez S, Llupià A, Puyol L, Rodrigo Melero N, Carolis C, Mayor A, Izquierdo L, Varela P, Trilla A, Vilella A, Barroso S, Angulo A, Engel P, Tortajada M, García-Basteiro AL, Dobaño C.
PMID: 35032961
EBioMedicine. 2022 Jan 11;75:103805. doi: 10.1016/j.ebiom.2021.103805. Epub 2022 Jan 11.

BACKGROUND: Two doses of mRNA vaccination have shown >94% efficacy at preventing COVID-19 mostly in naïve adults, but it is not clear if the second dose is needed to maximize effectiveness in those previously exposed to SARS-CoV-2 and what...

Cite
Moncunill G, Aguilar R, Ribes M, et al. Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers. EBioMedicine. 2022;75:103805doi: 10.1016/j.ebiom.2021.103805.
Moncunill, G., Aguilar, R., Ribes, M., Ortega, N., Rubio, R., Salmerón, G., Molina, M. J., Vidal, M., Barrios, D., Mitchell, R. A., Jiménez, A., Castellana, C., Hernández-Luis, P., Rodó, P., Méndez, S., Llupià, A., Puyol, L., Rodrigo Melero, N., Carolis, C., Mayor, A., Izquierdo, L., Varela, P., Trilla, A., Vilella, A., Barroso, S., Angulo, A., Engel, P., Tortajada, M., García-Basteiro, A. L., & Dobaño, C. (2022). Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers. EBioMedicine, 75103805. https://doi.org/10.1016/j.ebiom.2021.103805
Moncunill, Gemma, et al. "Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers." EBioMedicine vol. 75 (2022): 103805. doi: https://doi.org/10.1016/j.ebiom.2021.103805
Moncunill G, Aguilar R, Ribes M, Ortega N, Rubio R, Salmerón G, Molina MJ, Vidal M, Barrios D, Mitchell RA, Jiménez A, Castellana C, Hernández-Luis P, Rodó P, Méndez S, Llupià A, Puyol L, Rodrigo Melero N, Carolis C, Mayor A, Izquierdo L, Varela P, Trilla A, Vilella A, Barroso S, Angulo A, Engel P, Tortajada M, García-Basteiro AL, Dobaño C. Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers. EBioMedicine. 2022 Jan 11;75:103805. doi: 10.1016/j.ebiom.2021.103805. Epub 2022 Jan 11. PMID: 35032961.
Copy Download .nbib Format: NLM
Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Before Starting Chemotherapy.

JAMA network open

Hu X, Chehal PK, Kaplan C, Krukowski RA, Lan RH, Stepanski E, Schwartzberg L, Vidal G, Graetz I.
PMID: 34061200
JAMA Netw Open. 2021 Jun 01;4(6):e2112076. doi: 10.1001/jamanetworkopen.2021.12076.

IMPORTANCE: Race disparities persist in breast cancer mortality rates. One factor associated with these disparities may be differences in symptom burden, which may reduce chemotherapy tolerance and increase early treatment discontinuation.OBJECTIVES: To compare symptom burden by race among women...

Cite
Hu X, Chehal PK, Kaplan C, et al. Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Before Starting Chemotherapy. JAMA Netw Open. 2021;4(6):e2112076doi: 10.1001/jamanetworkopen.2021.12076.
Hu, X., Chehal, P. K., Kaplan, C., Krukowski, R. A., Lan, R. H., Stepanski, E., Schwartzberg, L., Vidal, G., & Graetz, I. (2021). Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Before Starting Chemotherapy. JAMA network open, 4(6), e2112076. https://doi.org/10.1001/jamanetworkopen.2021.12076
Hu, Xin, et al. "Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Before Starting Chemotherapy." JAMA network open vol. 4,6 (2021): e2112076. doi: https://doi.org/10.1001/jamanetworkopen.2021.12076
Hu X, Chehal PK, Kaplan C, Krukowski RA, Lan RH, Stepanski E, Schwartzberg L, Vidal G, Graetz I. Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Before Starting Chemotherapy. JAMA Netw Open. 2021 Jun 01;4(6):e2112076. doi: 10.1001/jamanetworkopen.2021.12076. PMID: 34061200; PMCID: PMC8170541.
Copy Download .nbib Format: NLM
Showing 1897 to 1898 of 1898 entries